Woonsocket, R.I. -- CVS Caremark Corp.’s third-quarter profit rose 7.3%, to $868 million, driven by strong performances in its pharmacy businesses. Its performance topped Wall Street expectations.
Revenue for the three-month period ended September 30, 2011, rose 12% to $26.67 billion, from $23.71 billion.
Revenue in its pharmacy-services segment increased 26% $14.8 billion, boosted by a contract with Aetna Inc. and added business from the acquisition of Universal American Corp.'s Medicare prescription drug business.
